TABLE OF CONTENTS 1 INDUSTRY OVERVIEW 1.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry 1.1.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Overview 1.1.2 Terminology Definition in the Report 1.1.2.1 Capacity 1.1.2.2 Sales Volume 1.1.2.3 Sales Revenue 1.1.2.4 Ex-factory Price & Sales Price 1.1.2.5 Cost 1.1.2.6 Gross Margin 1.2 Products & Services Overview Scope 1.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug in the Industry Chain 1.4 Industry Dynamics & Regulations 1.5 Global Market Overview 2 UPSTREAM & MANUFACTURING 2.1 Raw Materials / Components 2.2 Procurement Methods & Channels 2.3 Cost Structure & Manufacturing 2.4 Industry Capacity Overview 2.5 Production Distribution by Geography 2.5.1 Production in Major Regions / Countries 2.5.2 Trade Flow Overview 3 PRODUCT SEGMENT 3.1 Product Segmentation Market (2017 to 2021E) 3.1.1 SGD-2083  Market 3.1.2 Crizanlizumab  Market 3.1.3 PF-04447943  Market 3.1.4 NVX-508  Market 3.1.5 Others  Market 3.2 Market Status 4 APPLICATION / END-USE SEGMENT 4.1 Application Segmentation Market (2016 to 2021E) 4.1.1 Clinic  Market 4.1.2 Hospital  Market 4.1.3 Others Market 4.2 Market Status 5 NORTH AMERICA 5.1 North America Market Growth 5.2 North America Market by Countries 5.3 Major Countries Market Growth 5.3.1 United States Market Size and Growth (2016-2021E) 5.3.2 Canada Market Size and Growth (2016-2021E) 5.3.3 Mexico Market Size and Growth (2016-2021E) 6 EUROPE 6.1 Europe Market Growth 6.2 Europe Market by Countries 6.3 Major Countries Market Growth 6.3.1 Germany Market Size and Growth (2016-2021E) 6.3.2 UK Market Size and Growth (2016-2021E) 6.3.3 France Market Size and Growth (2016-2021E) 6.3.4 Russia Market Size and Growth (2016-2021E) 6.3.5 Italy Market Size and Growth (2016-2021E) 6.3.6 Rest of Europe Market Size and Growth (2016-2021E) 7 ASIA-PACIFIC 7.1 ASIA-PACIFIC Market Growth 7.2 ASIA-PACIFIC Market by Countries 7.3 Major Countries Market Growth 7.3.1 China Market Size and Growth (2016-2021E) 7.3.2 India Market Size and Growth (2016-2021E) 7.3.3 Japan Market Size and Growth (2016-2021E) 7.3.4 South Korea Market Size and Growth (2016-2021E) 7.3.5 Southeast Asia Market Size and Growth (2016-2021E) 7.3.6 Australia Market Size and Growth (2016-2021E) 7.3.7 Rest of Asia Pacific Market Size and Growth (2016-2021E) 8 SOUTH AMERICA 8.1 South America Market Growth 8.2 South America Market by Countries 8.3 Major Countries Market Growth 8.3.1 Brazil Market Size and Growth (2016-2021E) 8.3.2 Argentina Market Size and Growth (2016-2021E) 8.3.3 Rest of South America Market Size and Growth (2016-2021E) 9 MIDDLE EAST & AFRICA 9.1 Middle East and Africa Market Growth 9.2 Middle East and Africa Market by Countries 9.3 Major Countries Market Growth 9.3.1 GCC Market Size and Growth (2016-2021E) 9.3.2 North Africa Market Size and Growth (2016-2021E) 9.3.3 South Africa Market Size and Growth (2016-2021E) 9.3.4 Rest of Middle East & Africa Market Size and Growth (2016-2021E) 10 MARKET FORECAST 10.1 Global Market Forecast Overview 10.2 Global Market Forecast by Type 10.3 Global Market Forecast by Application / End-Use 10.4 Global Market Forecast by Region 11 COMPETITION OF MAJOR PLAYERS 11.1 AstraZeneca Plc  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.1.1 AstraZeneca Plc  Profile 11.1.2 AstraZeneca Plc  Products & Services Overview 11.1.3 AstraZeneca Plc  Main Business 11.1.4 AstraZeneca Plc  Business Operation 11.2 Bristol-Myers Squibb Company  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.2.1 Bristol-Myers Squibb Company  Profile 11.2.2 Bristol-Myers Squibb Company  Products & Services 11.2.3 Bristol-Myers Squibb Company  Main Business 11.2.4 Bristol-Myers Squibb Company  Business Operation 11.3 Gilead Sciences Inc  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.3.1 Gilead Sciences Inc  Profile 11.3.2 Gilead Sciences Inc  Products & Services 11.3.3 Gilead Sciences Inc  Main Business 11.3.4 Gilead Sciences Inc  Business Operation 11.4 Modus Therapeutics Holding AB  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.4.1 Modus Therapeutics Holding AB  Profile 11.4.2 Modus Therapeutics Holding AB  Products & Services 11.4.3 Modus Therapeutics Holding AB  Main Business 11.4.4 Modus Therapeutics Holding AB  Business Operation 11.5 Novartis AG  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.5.1 Novartis AG  Profile 11.5.2 Novartis AG  Products & Services 11.5.3 Novartis AG  Main Business 11.5.4 Novartis AG  Business Operation 11.6 NuvOx Pharma LLC  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.6.1 NuvOx Pharma LLC  Profile 11.6.2 NuvOx Pharma LLC  Products & Services 11.6.3 NuvOx Pharma LLC  Main Business 11.6.4 NuvOx Pharma LLC  Business Operation 11.7 Pfizer Inc  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.7.1 Pfizer Inc  Profile 11.7.2 Pfizer Inc  Products & Services 11.7.3 Pfizer Inc  Main Business 11.7.4 Pfizer Inc  Business Operation 11.8 Seattle Genetics Inc  (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.8.1 Seattle Genetics Inc  Profile 11.8.2 Seattle Genetics Inc  Products & Services 11.8.3 Seattle Genetics Inc  Main Business 11.8.4 Seattle Genetics Inc  Business Operation 12 COMPANY COMPETITION 12.1 Global Sales by Company 12.1.1 Global Sales by Company 12.1.2 Global Sales Share by Company 12.2 Price & Gross Margin 12.3 Landscape of Major Companies in the Market 12.3.1 Major Companies Product Type List 12.3.1 Manufacturing Regions and Headquarters of Major Companies 12.3.1 Mergers & Acquisitions 12.4 Competitive Environment for New Entrants 12.4.1 Michael Porter's Five Forces Model 12.4.2 SWOT 13 ENVIRONMENT OVERVIEW 13.1 Impact of COVID-19 13.2 Geopolitics Overview 13.3 Economic Overview of Major Countries 14 RESEARCH CONCLUSION

LIST OF TABLE TABLE ~ Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Industry Dynamics & Regulations List TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Volume, Revenue, Price, Cost and Margin, 2016-2021E TABLE ~ SGD-2083  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ SGD-2083  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Crizanlizumab  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Crizanlizumab  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ PF-04447943  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ PF-04447943  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ NVX-508  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ NVX-508  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Others  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Others  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type, 2016-2021E, in Volume TABLE ~ Clinic  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Clinic  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Hospital  Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Hospital  Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size by Type, 2016-2021E, in Volume TABLE ~ North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in USD Million TABLE ~ North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in USD Million TABLE ~ North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in Volume TABLE ~ North America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in Volume TABLE ~ United States Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Canada Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Mexico Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in USD Million TABLE ~ Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in Volume TABLE ~ Europe Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in Volume TABLE ~ Germany Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ UK Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ France Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Russia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Italy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Europe Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ ASIA-PACIFIC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in Volume TABLE ~ ASIA-PACIFIC Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in Volume TABLE ~ China Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ India Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Japan Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Korea Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Southeast Asia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Australia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Asia Pacific Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in USD Million TABLE ~ South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in USD Million TABLE ~ South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in Volume TABLE ~ South America Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in Volume TABLE ~ Brazil Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Argentina Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of South America Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Countries 2016-2021E, in Volume TABLE ~ Middle East and Africa Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Countries 2016-2021E, in Volume TABLE ~ GCC Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ North Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Middle East & Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Type 2022F-2026F, in Volume TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Type 2022F-2026F, in Volume TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Forecast by Region 2022F-2026F, in Volume TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share Forecast by Region 2022F-2026F, in Volume TABLE ~ AstraZeneca Plc  Overview List TABLE ~ Products & Services List of AstraZeneca Plc  TABLE ~ Business Operation of AstraZeneca Plc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Bristol-Myers Squibb Company  Overview List TABLE ~ Products & Services List of Bristol-Myers Squibb Company  TABLE ~ Business Operation of Bristol-Myers Squibb Company  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Gilead Sciences Inc  Overview List TABLE ~ Products & Services List of Gilead Sciences Inc  TABLE ~ Business Operation of Gilead Sciences Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Modus Therapeutics Holding AB  Overview List TABLE ~ Products & Services List of Modus Therapeutics Holding AB  TABLE ~ Business Operation of Modus Therapeutics Holding AB  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Novartis AG  Overview List TABLE ~ Products & Services List of Novartis AG  TABLE ~ Business Operation of Novartis AG  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ NuvOx Pharma LLC  Overview List TABLE ~ Products & Services List of NuvOx Pharma LLC  TABLE ~ Business Operation of NuvOx Pharma LLC  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Pfizer Inc  Overview List TABLE ~ Products & Services List of Pfizer Inc  TABLE ~ Business Operation of Pfizer Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Seattle Genetics Inc  Overview List TABLE ~ Products & Services List of Seattle Genetics Inc  TABLE ~ Business Operation of Seattle Genetics Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Company 2016-2021E, in USD Million TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales by Company 2016-2021E, in Volume TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Company 2016-2021E, in USD Million TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share by Company 2016-2021E, in Volume TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Price by Company 2016-2021E, in USD/Volume TABLE ~ Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Gross Margin by Company 2016-2021E TABLE ~ Major Companies Product Type List TABLE ~ Major Companies Product Type List TABLE ~ Mergers & Acquisitions in the Market